CIK 0001725160 · Non-accelerated filer<br>Smaller reporting company
Zentalis Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ZNTL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 823607803
- Phone
- (858) 263-4333
- Business address
- 10275 SCIENCE CENTER DRIVE, SUITE 200, SAN DIEGO, CA, 92121
- Former names
- Zentalis Pharmaceuticals, LLC, Zeno Pharma, LLC
- 4 Insider Changes in Ownership
- UPLOAD Other SEC-generated Letter
- 3 Insider Initial Statement of Ownership
- SC 13D Stake Beneficial Ownership Report
- 4 Insider Changes in Ownership
- DEFA14A Proxy Proxy Materials
- 8-K Event Executive or director change
- CORRESP Other Correspondence Between Filers and SEC Staff
- 8-K Event Delisting notice
- 4 Insider Changes in Ownership
- DEFA14A Proxy Proxy Materials
- 8-K Event Other events
- 424B5 Offering Prospectus
- 8-K Event Executive or director change
- UPLOAD Other SEC-generated Letter
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 424B5 Offering Prospectus
Page 16 of 28 · 548 filings